AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-MEDICAL LABORATORIES
Quest Diagnostics Inc.
XNYS · usd
SIC 8071 · SERVICES-MEDICAL LABORATORIES
FIGI BBG001S9GX43
230.97▲ 0.16 (0.07%)
As of 2026-10-09
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
230.81
Day's Range
227.86 – 232.18
52-Week Range
171.01 – 248.84
Volume
775.4K
Avg Volume
1.1M
Share Statistics
Shares Outstanding
Employees
57.0K
Exchange
XNYS
Listed
1996-12-17
Share count as of July 15, 2026

Quest Diagnostics Inc. (DGX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Quest Diagnostics Inc. (DGX)
What is Quest Diagnostics Inc.'s Market Cap?
Quest Diagnostics Inc.'s Market Cap is $25.5B, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s Enterprise Value?
Quest Diagnostics Inc.'s Enterprise Value is $30.5B, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s Trailing P/E?
Quest Diagnostics Inc.'s Trailing P/E is 24.0×, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s Price / Sales?
Quest Diagnostics Inc.'s Price / Sales is 2.2×, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s EV / Revenue?
Quest Diagnostics Inc.'s EV / Revenue is 2.6×, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s EV / EBITDA?
Quest Diagnostics Inc.'s EV / EBITDA is 13.8×, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s Revenue (TTM)?
Quest Diagnostics Inc.'s Revenue (TTM) is $11.6B, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s Net Income (TTM)?
Quest Diagnostics Inc.'s Net Income (TTM) is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s EBITDA?
Quest Diagnostics Inc.'s EBITDA is $2.2B, based on as-reported figures from SEC (XBRL) filings.
What is Quest Diagnostics Inc.'s Diluted EPS (TTM)?
Quest Diagnostics Inc.'s Diluted EPS (TTM) is 9.62, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · DGXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net revenues
YoY growth+10.2%+9.2%+7.1%+13.2%
Operating costs and expenses and other operating income:
Cost of services
Selling, general and administrative
Amortization of intangible assets
Other operating expense (income), net
Total operating costs and expenses, net
% of revenue84.9%86.2%86.2%86.3%
Operating income
% of revenue15.1%13.8%13.8%13.7%
Other income (expense):
Interest expense, net
Other income, net
Total non-operating expense, net
Income before income taxes and equity in earnings of equity method investees
Income tax expense
Equity in earnings of equity method investees, net of taxes
Net income
% of revenue11.0%9.1%9.1%9.2%
Less: Net income attributable to noncontrolling interests
Net income attributable to Quest Diagnostics
% of revenue10.5%8.7%8.7%8.7%
Earnings per share attributable to Quest Diagnostics’ common stockholders:
Basic (in dollars per share)—
Diluted (in dollars per share)—